Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Costain refinances bank and bonding facilities

(Sharecast News) - Construction and engineering firm Costain said on Wednesday that it has successfully refinanced its bank and bonding facilities. Costain said it had secured a new four-year agreement that will extend its facilities until September 2029, with an option to extend for an additional year.

The FTSE 250-listed firm stated the new facility agreements, which replace its previous three-year agreements, include a £100.0m revolving credit facility and bonding facilities totalling £295.0m.

Cosain said its new revolving credit facility was backed by a group of five banks, including Lloyds Bank, as well as Crédit Industriel et Commercial, HSBC, National Westminster Bank and Banco de Sabadell.

Chief executive Alex Vaughan said: "I am pleased that we have successfully secured a new four-year RCF and that Banco de Sabadell has joined our banking group. The success of this refinancing demonstrates the strong confidence our lenders and bond providers have in our business model, strategic plans and balance sheet strength."

As of 1020 BST, Costain shares were down 0.31% at 123.42p.

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.